ID

28370

Descripción

The primary objective of the study is to assess the clinical effects of natalizumab versus placebo in acute ischemic stroke on clinical measures of functional independence and activities of daily living. The secondary objective of the study is to explore dose and exposure response and the clinical treatment effects of natalizumab versus placebo in acute ischemic stroke on the following: measures of independence, activities of daily living, neurologic function, quality of life, cognition, and safety and tolerability. https://clinicaltrials.gov/ct2/show/study/NCT02730455.

Link

https://clinicaltrials.gov/ct2/show/study/NCT02730455

Palabras clave

Versiones (1)
  1. 8/1/18 8/1/18 -
Titular de derechos de autor

Biogen

Subido en

8 de enero de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility criteria ACTION 2 Acute Ischemic Stroke NCT02730455

Inglés

Eligibility criteria ACTION 2 Acute Ischemic Stroke NCT02730455

1 formularios  
Key Inclusion Criteria
Descripción

Key Inclusion Criteria

Age 18 to 80 Years
Descripción

Age

Tipo de datos

boolean

Clinical diagnosis of supratentorial acute ischemic stroke defined by LKN ≤24 hours prior to study treatment initiation
Descripción

diagnosis of stroke

Tipo de datos

boolean

Score of 5 to 23 points, inclusive, on the NIHSS at Screening for subjects initiating treatment ≤9 hours from LKN
Descripción

Note: NIHSS eligibility must be confirmed within 60 minutes prior to randomization

Tipo de datos

boolean

Score of 5 to 15 points, inclusive, on the NIHSS at Screening for subjects initiating treatment >9 to ≤24 hours from LKN
Descripción

Note: NIHSS eligibility must be confirmed within 60 minutes prior to randomization

Tipo de datos

boolean

Prior to index stroke, patient was able to perform basic activities of daily living without assistance: dressing, eating, walking, bathing, and using the toilet
Descripción

basic activities of daily living

Tipo de datos

boolean

For those subjects who underwent a cranial MRI, there is at least 1 acute infarct with a diameter of ≥2 cm on baseline brain diffusion-weighted imaging
Descripción

acute infarct diameter MRI

Tipo de datos

boolean

Key Exclusion Criteria
Descripción

Key Exclusion Criteria

Lacunar or isolated brainstem or cerebellar stroke based on clinical assessment and available acute imaging studies performed under the standard of care
Descripción

brainstem or cerebellar stroke

Tipo de datos

boolean

Presence of acute intracranial hemorrhage on acute brain CT or MRI. However, petechial hemorrhages of ≤1 cm are not exclusionary
Descripción

acute intracranial hemorrhage

Tipo de datos

boolean

Severe stroke defined by imaging criteria based on either one of the following: Alberta Stroke Program Early CT (ASPECT) score of 0 to 4 based on head CT or Acute infarct volume on MRI diffusion weighed imaging greater than or equal to 70 mL
Descripción

Severe stroke

Tipo de datos

boolean

Seizure at the onset of stroke
Descripción

Seizure

Tipo de datos

boolean

Known history of prior treatment with natalizumab
Descripción

natalizumab

Tipo de datos

boolean

Known history of active viral hepatitis B or C
Descripción

hepatitis B or C

Tipo de datos

boolean

Signs and symptoms of active or acute infection
Descripción

infection

Tipo de datos

boolean

Volver a la parte superior de la página

Similar models

Eligibility criteria ACTION 2 Acute Ischemic Stroke NCT02730455

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Key Inclusion Criteria
Age
Item
Age 18 to 80 Years
boolean
diagnosis of stroke
Item
Clinical diagnosis of supratentorial acute ischemic stroke defined by LKN ≤24 hours prior to study treatment initiation
boolean
NIHSS score within 9 hours of last known normal
Item
Score of 5 to 23 points, inclusive, on the NIHSS at Screening for subjects initiating treatment ≤9 hours from LKN
boolean
NIHSS score 9-24 hours after last known normal
Item
Score of 5 to 15 points, inclusive, on the NIHSS at Screening for subjects initiating treatment >9 to ≤24 hours from LKN
boolean
basic activities of daily living
Item
Prior to index stroke, patient was able to perform basic activities of daily living without assistance: dressing, eating, walking, bathing, and using the toilet
boolean
acute infarct diameter MRI
Item
For those subjects who underwent a cranial MRI, there is at least 1 acute infarct with a diameter of ≥2 cm on baseline brain diffusion-weighted imaging
boolean
Item Group
Key Exclusion Criteria
brainstem or cerebellar stroke
Item
Lacunar or isolated brainstem or cerebellar stroke based on clinical assessment and available acute imaging studies performed under the standard of care
boolean
acute intracranial hemorrhage
Item
Presence of acute intracranial hemorrhage on acute brain CT or MRI. However, petechial hemorrhages of ≤1 cm are not exclusionary
boolean
Severe stroke
Item
Severe stroke defined by imaging criteria based on either one of the following: Alberta Stroke Program Early CT (ASPECT) score of 0 to 4 based on head CT or Acute infarct volume on MRI diffusion weighed imaging greater than or equal to 70 mL
boolean
Seizure
Item
Seizure at the onset of stroke
boolean
natalizumab
Item
Known history of prior treatment with natalizumab
boolean
hepatitis B or C
Item
Known history of active viral hepatitis B or C
boolean
infection
Item
Signs and symptoms of active or acute infection
boolean
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial